Latest News Archive
Please select Category, Year, and then Month to display items
02 April 2019
|
Story Valentino Ndaba
|
Photo Charl Devenish
Pictured are 8 of the 64 UFS School of Accountancy students who form part of the 84.2% pass rate achievers.
Students from the University of the Free State (UFS) School of Accountancy achieved a 84.2% pass rate compared to the national average of 76.2% during the Initial Test of Competence (ITC) examination facilitated by the South African Institute of Chartered Accountants (SAICA).
A total of 64 out of 76 UFS students who attempted the ITC for the first time were successful in the examination. The ITC is known for its challenging nature. Demographically, our African black students outperformed the 62.1% national pass rate by attaining an impressive 80.6%.
Collective congratulations
Prof Hentie van Wyk, Programme Director at the school, attributed diligence for the high pass rate. “This is due to our student-centred teaching module that was introduced four years ago and committed academic staff of the School of Accountancy from the first to the fourth year.”
Further future surge expected
“With the coming June 2019 ITC sitting, our pass rate for 2019 will most probably be more than 90%. Our three-year rolling average for 2015-2017, 2016-2018 and 2017-2019 were 83%, 86% and 90% respectively. Hopefully we can maintain the upward curve,” said Prof Van Wyk.
UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08
The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.
The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.
The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.
“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.
“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.
According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.
The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.
According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.
The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.
Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004